Go to the Globe and Mail homepage

Jump to main navigationJump to main content


J&J profit falls 6 per cent Add to ...

Johnson & Johnson posts a 6-per-cent decline in third-quarter profit, as larger overhead and production costs and a one-time charge offset higher foreign sales.

The health care giant says profit was $3.2-billion, or $1.15 per share. That’s down from $3.42-billion, or $1.23 per share, a year earlier.

Excluding a 9-cent charge for the pending acquisition of medical device maker Synthes Inc., profit would have been $3.4-billion, or $1.24 per share.

The maker of baby products and biologic drugs had revenue totalling $16-billion, up 7 per cent from a year ago.

Analysts polled by FactSet were expecting earnings per share of $1.21 and sales of $16.02-billion.

Sales in all J&J three divisions were down in the U.S.

Report Typo/Error

Follow us on Twitter: @GlobeInvestor

  • Johnson & Johnson
  • Updated November 17 4:01 PM EST. Delayed by at least 15 minutes.

More related to this story

Next story




Most popular videos »

More from The Globe and Mail

Most popular